| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.4 | 0.005 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.38 | 0.007 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.23 | 0.09 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |